The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies

Brian G Murphy, M. Perron, E. Murakami, K. Bauer, Y. Park, C. Eckstrand, M. Liepnieks, Niels C Pedersen

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Feline infectious peritonitis (FIP) is a common and highly lethal coronavirus disease of domestic cats. Recent studies of diseases caused by several RNA viruses in people and other species indicate that antiviral therapy may be effective against FIP in cats. The small molecule nucleoside analog GS-441524 is a molecular precursor to a pharmacologically active nucleoside triphosphate molecule. These analogs act as an alternative substrate and RNA-chain terminator of viral RNA dependent RNA polymerase. We determined that GS-441524 was non-toxic in feline cells at concentrations as high as 100 uM and effectively inhibited FIPV replication in cultured CRFK cells and in naturally infected feline peritoneal macrophages at concentrations as low as 1 uM. We determined the pharmacokinetics of GS-441524 in cats in vivo and established a dosage that would sustain effective blood levels for 24 h. In an experimental FIPV infection of cats, GS-441524 treatment caused a rapid reversal of disease signs and return to normality with as little as two weeks of treatment in 10/10 cats and with no apparent toxicity.

Original languageEnglish (US)
Pages (from-to)226-233
Number of pages8
JournalVeterinary Microbiology
Volume219
DOIs
StatePublished - Jun 1 2018

Fingerprint

Feline Coronavirus
Feline coronavirus
nucleosides
Nucleosides
tissue culture
Cats
cats
Feline Infectious Peritonitis
Infection
infection
Felidae
feline infectious peritonitis
RNA Replicase
Coronavirus
RNA-directed RNA polymerase
RNA Viruses
Viral RNA
Peritoneal Macrophages
Antiviral Agents
Coronavirinae

Keywords

  • Cell culture
  • EC50
  • Experimental infection
  • Feline infectious peritonitis (FIP)
  • FIP virus (FIPV)
  • GS-441524
  • Laboratory cats
  • Nucleoside analog
  • Pharmacokinetics
  • Tri-phosphorylation

ASJC Scopus subject areas

  • Microbiology
  • veterinary(all)

Cite this

The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. / Murphy, Brian G; Perron, M.; Murakami, E.; Bauer, K.; Park, Y.; Eckstrand, C.; Liepnieks, M.; Pedersen, Niels C.

In: Veterinary Microbiology, Vol. 219, 01.06.2018, p. 226-233.

Research output: Contribution to journalArticle

@article{86eb29887eb149b280acb23cbc25654f,
title = "The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies",
abstract = "Feline infectious peritonitis (FIP) is a common and highly lethal coronavirus disease of domestic cats. Recent studies of diseases caused by several RNA viruses in people and other species indicate that antiviral therapy may be effective against FIP in cats. The small molecule nucleoside analog GS-441524 is a molecular precursor to a pharmacologically active nucleoside triphosphate molecule. These analogs act as an alternative substrate and RNA-chain terminator of viral RNA dependent RNA polymerase. We determined that GS-441524 was non-toxic in feline cells at concentrations as high as 100 uM and effectively inhibited FIPV replication in cultured CRFK cells and in naturally infected feline peritoneal macrophages at concentrations as low as 1 uM. We determined the pharmacokinetics of GS-441524 in cats in vivo and established a dosage that would sustain effective blood levels for 24 h. In an experimental FIPV infection of cats, GS-441524 treatment caused a rapid reversal of disease signs and return to normality with as little as two weeks of treatment in 10/10 cats and with no apparent toxicity.",
keywords = "Cell culture, EC50, Experimental infection, Feline infectious peritonitis (FIP), FIP virus (FIPV), GS-441524, Laboratory cats, Nucleoside analog, Pharmacokinetics, Tri-phosphorylation",
author = "Murphy, {Brian G} and M. Perron and E. Murakami and K. Bauer and Y. Park and C. Eckstrand and M. Liepnieks and Pedersen, {Niels C}",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.vetmic.2018.04.026",
language = "English (US)",
volume = "219",
pages = "226--233",
journal = "Veterinary Microbiology",
issn = "0378-1135",
publisher = "Elsevier",

}

TY - JOUR

T1 - The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies

AU - Murphy, Brian G

AU - Perron, M.

AU - Murakami, E.

AU - Bauer, K.

AU - Park, Y.

AU - Eckstrand, C.

AU - Liepnieks, M.

AU - Pedersen, Niels C

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Feline infectious peritonitis (FIP) is a common and highly lethal coronavirus disease of domestic cats. Recent studies of diseases caused by several RNA viruses in people and other species indicate that antiviral therapy may be effective against FIP in cats. The small molecule nucleoside analog GS-441524 is a molecular precursor to a pharmacologically active nucleoside triphosphate molecule. These analogs act as an alternative substrate and RNA-chain terminator of viral RNA dependent RNA polymerase. We determined that GS-441524 was non-toxic in feline cells at concentrations as high as 100 uM and effectively inhibited FIPV replication in cultured CRFK cells and in naturally infected feline peritoneal macrophages at concentrations as low as 1 uM. We determined the pharmacokinetics of GS-441524 in cats in vivo and established a dosage that would sustain effective blood levels for 24 h. In an experimental FIPV infection of cats, GS-441524 treatment caused a rapid reversal of disease signs and return to normality with as little as two weeks of treatment in 10/10 cats and with no apparent toxicity.

AB - Feline infectious peritonitis (FIP) is a common and highly lethal coronavirus disease of domestic cats. Recent studies of diseases caused by several RNA viruses in people and other species indicate that antiviral therapy may be effective against FIP in cats. The small molecule nucleoside analog GS-441524 is a molecular precursor to a pharmacologically active nucleoside triphosphate molecule. These analogs act as an alternative substrate and RNA-chain terminator of viral RNA dependent RNA polymerase. We determined that GS-441524 was non-toxic in feline cells at concentrations as high as 100 uM and effectively inhibited FIPV replication in cultured CRFK cells and in naturally infected feline peritoneal macrophages at concentrations as low as 1 uM. We determined the pharmacokinetics of GS-441524 in cats in vivo and established a dosage that would sustain effective blood levels for 24 h. In an experimental FIPV infection of cats, GS-441524 treatment caused a rapid reversal of disease signs and return to normality with as little as two weeks of treatment in 10/10 cats and with no apparent toxicity.

KW - Cell culture

KW - EC50

KW - Experimental infection

KW - Feline infectious peritonitis (FIP)

KW - FIP virus (FIPV)

KW - GS-441524

KW - Laboratory cats

KW - Nucleoside analog

KW - Pharmacokinetics

KW - Tri-phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=85052331308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052331308&partnerID=8YFLogxK

U2 - 10.1016/j.vetmic.2018.04.026

DO - 10.1016/j.vetmic.2018.04.026

M3 - Article

C2 - 29778200

AN - SCOPUS:85052331308

VL - 219

SP - 226

EP - 233

JO - Veterinary Microbiology

JF - Veterinary Microbiology

SN - 0378-1135

ER -